Gammagard Litigation

Represented approximately 29 individuals, most of them children, who contracted Hepatitis C from contaminated intravenous immune globulin, called Gammagard, manufactured by Baxter Healthcare, Inc.  Our firm was designated lead counsel in the Gammagard MDL Litigation venued in Federal Court in Los Angeles.  We also took the lead in conducting discovery in the MDL and negotiated an unique settlement agreement for its clients that provided immediate payment for damages resulting from living with Hepatitis C, an incurable chronic disease, and at the same time provided for future payments for complications that may arise from Hepatitis C, which has resulted in our clients obtaining additional settlement payments years later.  That settlement agreement became the model used to settle all individual Gammagard cases around the country as well as to settle a class action filed in Los Angeles.
Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Similar Results

Back to Top